Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Drug-Coated Balloons Market’s size between 2026 and 2030?

The drug-coated balloons market has experienced substantial growth in recent years. This market is anticipated to expand from $1.24 billion in 2025 to $1.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.5%. Historically, this expansion has been driven by factors such as the increasing prevalence of cardiovascular diseases, the expansion of interventional cardiology procedures, the early adoption of paclitaxel-coated balloons, a growing demand for restenosis prevention, and advancements in angioplasty techniques.

The drug-coated balloons market is projected to experience significant expansion over the next few years, with its size anticipated to reach $2.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.6%. This growth is primarily driven by factors such as the increasing application of DCB therapies in coronary uses, the rising adoption of next-generation coating technologies, the ongoing expansion of catheter-based interventions, growing investments in vascular innovation, and an increasing preference for stent-free treatment options. Furthermore, major developments expected during this period include the wider acceptance of sirolimus-coated balloons, the growing use of DCBs in peripheral artery disease, an increasing inclination towards minimally invasive vascular treatments, the proliferation of advanced drug-coating technologies, and a stronger emphasis on enhancing drug delivery efficiency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Drivers Are Shaping Strategic Decisions In The Drug-Coated Balloons Market?

The increasing prevalence of ambulatory surgery centers is projected to foster the expansion of the drug-coated balloon market in the future. An Ambulatory Surgical Center (ASC) functions as a medical establishment dedicated to performing surgical interventions that do not necessitate an overnight hospital stay. Drug-coated balloons hold significant importance in ambulatory surgery centers (ASC) as they typically facilitate quicker procedure times compared to conventional balloons, thereby enhancing patient throughput and lowering operational costs within ASCs. For instance, in March 2025, the Medicare Payment Advisory Commission (an independent U.S. federal advisory agency) indicated that from 2022 through 2023, the number of Medicare-certified ASCs grew by 2.5% to 6,308 ASCs, signifying a net rise of 155 facilities during 2023. Therefore, the growing number of ambulatory surgery centers is propelling the growth of the drug-coated balloon market.

What Segment Categories Are Covered In The Drug-Coated Balloons Market?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

Which Trends Are Guiding The Evolution Of The Drug-Coated Balloons Market?

Leading companies engaged in drug-coated balloons are prioritizing the advancement of their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis, enhance patient outcomes, and reduce the likelihood of complications associated with conventional therapies. Paclitaxel-coated balloon catheters are instruments engineered to release the drug paclitaxel into the artery wall when inflated, thereby helping to prevent re-narrowing after angioplasty. As an example, in March 2024, Boston Scientific Corporation, a US-based medical device company, secured US Food and Drug Administration (FDA) approval for its AGENTTM Drug-Coated Balloon (DCB). This device is designated for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a stented blood vessel experiences obstruction or narrowing due to plaque or scar tissue.

Which Key Players Are Driving Competition In The Drug-Coated Balloons Market?

Major companies operating in the drug-coated balloons market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., Lepu Medical Technology Co. Ltd, Balton Sp. z o.o., BrosMed Medical Co. Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

How Does The Drug-Coated Balloons Market Perform Across Major Global Regions?

North America was the largest region in the global drug-coated balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug-Coated Balloons Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2026, By The Business Research Company

Drug Eluting Balloons Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Intragastric Balloons Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Angioplasty Balloons Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company